The company
HCW Biologics Inc.
HCWB · Nasdaq
HCWB stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 69.1% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $1.1M
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 11 (-1)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Scott T. GarrettDirector | bought | 7,736at $2.59 | 29 Jul 2026filed 31 Jul 2026 |
| Lee FlowersSVP of Business Development | bought | 7,736at $2.59 | 29 Jul 2026filed 31 Jul 2026 |
| Hing C. WongChief Executive Officer | bought | 23,210at $2.59 | 29 Jul 2026filed 31 Jul 2026 |
| Rebecca ByamChief Financial Officer | bought | 14,235at $1.41 | 22 May 2026filed 27 May 2026 |
| Rebecca ByamChief Financial Officer | bought | 14,235at $0.00 | 22 May 2026filed 27 May 2026 |
| Scott T. GarrettDirector | bought | 177,936at $1.41 | 22 May 2026filed 27 May 2026 |
| Scott T. GarrettDirector | bought | 177,936at $0.00 | 22 May 2026filed 27 May 2026 |
| Hing C. WongChief Executive Officer | bought | 113,879at $1.41 | 22 May 2026filed 27 May 2026 |
| Hing C. WongChief Executive Officer | bought | 113,879at $0.00 | 22 May 2026filed 27 May 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| JANE STREET GROUP, LLCadded · filed 14 Aug 2026 | 52,138$260K | +38,004+268.9% |
| CITADEL ADVISORS LLCreduced · filed 14 Aug 2026 | 19,942$100K | -6,141−23.5% |
| VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026 | 6,510$32K | +4,607+242.1% |
| Tower Research Capital LLC (TRC)reduced · filed 11 Aug 2026 | 4,117$21K | -10,722−72.3% |
| Connective Capital Management, LLCnew · filed 13 Aug 2026 | 3,338$17K | +3,338 |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 2,003$9,995 | -10,020−83.3% |
| Golden State Wealth Management, LLCreduced · filed 22 Jul 2026 | 1,667$8,318 | -8,333−83.3% |
| BARCLAYS PLCnew · filed 14 Aug 2026 | 191$953 | +191 |
| Caitong International Asset Management Co., Ltdnew · filed 5 Aug 2026 | 11$10 | +11 |
| OSAIC HOLDINGS, INC.reduced · filed 14 Aug 2026 | 4$20 | -22−84.6% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.